The growth and activity of metal-reducing microorganisms are affected by the interaction of environmental factors, including iron mineral type and content, pH, and carbon substrate concentration -factors that cause variations in the performance of biological iron reduction [10, 11] . Previous research found that the extent of the reductive dissolution of highly crystalline iron minerals is lower than the reduction of amorphous and poorly crystalline iron oxyhydroxides [10] . Bose et al. (2009) [12] reported that the reductive dissolution rate of hematite nanoparticles are not always positively correlated with particle size, whereas Yan et al. (2008) [13] suggested that the bacteria-hematite contact surface area may be the dominant factor affecting iron reduction instead of the total hematite surface area. Iron minerals are usually present within soil aggregates, which might suppress the contact and reduction of metal-reducing microorganisms (e.g., Shewanella oneidensis). Thus, the performance of iron reduction is infl uenced by different aggregate structure properties of soils. Electron shuttle compounds (i.e., anthraquinone-2,6-disulfonate (AQDS), humic acid, and fl avin) have been reported to assist metal-reducing microorganisms in the bioreduction of iron minerals far from the bacteria or within small pore structures that inhibit the entrances of bacteria [14] . Low levels of humic acid as an electron shuttle compound limit or inhibit ferrihydrite bioreduction, whereas the decrease in ferrihydrite concentration or the increase in humic acid levels increases Fe(II) ion concentrations [15] . Different types of soil present unique aggregate structures in nature and may affect biological iron reduction even with the electron shuttle mechanism.
This study aimed to improve the understanding of iron reduction in soils/sediments with different structural properties and environmental conditions. The hydrogel encapsulation technique was used to prepare hydrogelencapsulated iron oxyhydroxides and soil to simulate soil aggregates with different structural properties. Anaerobic batch experiments were conducted to investigate the kinetics of iron reduction in aggregates using the typical iron reducer S. oneidensis MR-1 and electron shuttle AQDS. A reductive dissolution kinetic model was also used to characterize the experimental data and provide further information on the iron reduction of different aggregates.
Materials and Methods

Materials
S. Oneidensis MR-1 Preparation
S. oneidensis MR-1 cells were cultured at 25ºC in Luria-Bertani medium, which contained 10 g L −1 tryptone, 5 g L −1 yeast extract, and 5 g L −1 NaCl with pH 7.0. After centrifuging at 7,000 rpm for 15 min at 4ºC, the harvested cells were washed three times with 12 mmol L −1 HEPES (N-2-hydroxyethylpiperazine-N›-2-ethanesulphonic acid)-pH buffer solution [16] . The suspensions of S.oneidensis MR-1 cells were collected and used for iron reduction experiments.
Synthetic Goethite Preparation
Synthetic goethite (α-FeOOH) was prepared following the procedure of Lovley and Phillips (1986) [17] . In brief, the pH of a 0.4 mol L −1 FeCl 3 solution was adjusted to 12.0 with NaOH solution. After one week at room temperature, the solution was incubated at 90ºC for 16 h and then freeze-dried. According to X-ray diffraction analysis, the synthetic iron oxide was confi rmed to be goethite.
Experimental Soil
R-soil samples were collected from Fujian Province in southern China. According to the Chinese soil classifi cation, the R-soil sample was Ferrisol, which was classifi ed as a typical kandiudult according to the United States Department of Agriculture (USDA) and as ferric acrisols according to the FAO/UNESCO soil classifi cation system. The physicochemical characteristics of the experimental soils are presented in Table 1 .
Preparation of Hydrogel-Encapsulated Aggregates
Hydrogel-encapsulated aggregates were prepared according to a modifi ed Spalding's procedure [18] . A total of 0.4 g of synthetic goethite (or 1 g of soil) was mixed and stirred with 2 mL of hydrogel-forming solution in a 2.5 mL syringe that contains 14% monomer acrylamide, 0.1% ammonium persulfate, 0.06% tetramethylethylenediamine, and 0.3% or 2% cross-linker N,N′-methylene-bis-acrylamide (all at weight/volume). After initial polymerization, the syringes were stored at 4ºC overnight to complete the polymerization process.
The hydrogel-encapsulated aggregates were then removed from the syringes. The aggregates were rinsed three times with deionized water, cut into small pieces with 0.5 cm depth, and stored under water-saturated conditions. The structural properties of the aggregates are listed in Table 2 .
Biological Iron Reduction Experiments
Iron reduction experiments were conducted in LML medium containing 10 mmol L −1 lactate as electron donor and 12 mmol L −1 HEPES as pH buffer [16] . A total of 29 mL of LML medium and certain grams of hydrogelencapsulated goethite/soils were placed in 60 mL serum bottles, the headspaces of which were replaced with pure N 2 gas. The serum bottles were covered with butyl rubber stoppers and aluminum caps. About 1 mL of S. oneidensis MR-1 suspension was added into the bottle using a sterile syringe through the butyl rubber stopper. The mixture yielded a fi nal concentration of ~2 × 10 5 cells mL −1 , and the media were incubated at 25ºC in the dark. The sterilized samples were also subjected to treatment, with three replicates prepared for each treatment. The three-structure property treatments for either synthetic goethite or soil were as follows: a) hydrogel encapsulation at 0.3% cross-linker density, b) hydrogel encapsulation at 2% cross-linker density, and c) without hydrogel encapsulation. Concentrations of 3.3 and 6.6 g L −1 were used in the goethite experiment. In the soil experiment, 10 g L −1 soil was added to either aggregate. Traditional electron shuttle compound AQDS was also added into the LML medium in some experiments.
Sampling and Analysis
During the iron reduction experiments, 0.5 mL of suspension was sampled from the serum bottle using a sterilized syringe at intervals. The suspension was centrifuged at 10,000 rpm for 2 min. The concentration of Fe(II) ion in the supernatant was measured by phenanthroline spectrophotometry [11] .
Kinetic Modeling
The kinetic reductive dissolution of goethite was interpreted by a standard generalized rate law [19, 20] :
…where J t is the rate of reductive dissolution at time t, m 0 is the initial mass of iron, m t /m 0 is the non-reductive dissolved iron fraction, k is the initial rate constant, and γ is a controlling parameter of the long-term release extent of Fe(II) ion. As previously found by Davranche et al. (2013) [21] , the reductive dissolution data of iron can be well fi tted in OriginPro 8.0 (OriginLab corportation, USA) by the integrated form of Eq. (2):
Results
Iron Reduction of Soil Aggregates
with S. oneidensis MR-1 ). Thus, the structural property played an important role during the release of Fe(II) ion through biological iron reduction.
Iron Reduction of Goethite Aggregates with S. oneidensis MR-1
To understand the effects of structural property and AQDS addition on iron reduction, further experiments were conducted using goethite, which is one of the major bioavailable iron minerals in red earth soil. Fig. 2a shows ) rapidly increased ( ). However, with higher amounts of AQDS (150 or 300 μmol L −1 AQDS), the Fe(II) ion concentrations in unencapsulated goethite treatments were higher than those in treatments with 2% hydrogel encapsulation (Fig. 3) . The Fe(II) ion concentration in unencapsulated goethite treatment with 300 μmol L −1 AQDS quickly increased to over 47 mg L −1 on day 6, whereas the Fe(II) concentration in 2% hydrogel encapsulation treatment increased to only 40.35±5.96 mg L −1 after day 23 of incubation. , whereas the addition of AQDS in some treatments was 100 μmol L -1 . Fig. 2 . Dynamics of Fe(II) ion concentrations during biological iron reduction with goethite aggregates. Six treatments were prepared, namely goethite (right triangle), goethite with AQDS addition (circle), 0.3% hydrogel-encapsulated soil (left triangle), 0.3% hydrogel-encapsulated soil with AQDS addition (square), 2% hydrogel-encapsulated soil (down triangle), and 2% hydrogel-encapsulated soil with AQDS addition (up triangle). Two different kinds of goethite contents were prepared, namely 3.3 and 6.6 g L -1 . The concentration of AQDS in some treatments was 100 μmol L -1 . Biological Reduction of Hydrogel-Encapsulated...
Kinetic Analysis of the Biological Reductive Dissolution of Hydrogel-Encapsulated Goethite
A kinetic reductive dissolution model was used to simulate the data from the iron reduction experiment to further understand the iron reduction mechanism. goethite-AQDS. Parameter k and log γ were two parameters of the kinetic reductive dissolution model. As shown in Table 3 , in treatments with 6.6 g L −1 goethite, the addition of AQDS increased the value of k from 2.95×10 −4 to 5.37×10 −4 , but decreased the value of log γ from 3.32 to 3.09. In 3.3 g L −1
goethite treatment, the k and log γ values were both lower , while the concentrations of AQDS in four treatments were 0, 100, 150, and 300 μmol L than those in the treatment with the same concentration of AQDS added but with higher levels of goethite content.
In treatments with 6.6 g L −1 goethite, the value of k followed the sequence 0.3% hydrogel encapsulation with AQDS ≈ 2% hydrogel encapsulation with AQDS >> goethite with AQDS. By contrast, the order for k in treatments with 3.3 g L −1 goethite was 2% hydrogel encapsulation with AQDS > 0.3% hydrogel encapsulation with AQDS > goethite with AQDS. The value of log γ in treatments with 6.6 g L −1 goethite and 100 μmol L goethite showed the opposite trend.
Discussion
As shown in Fig. 1 , the release of Fe(II) ion from R-soil without AQDS addition was limited. Similarly, in 3.3 g L −1 goethite treatments with or without hydrogel encapsulation, the concentrations of Fe(II) ion were lower than 0.5 mg L −1 during incubation (Fig. 2a) . In treatments with 0.3% or 2% hydrogel-encapsulated soil/goethite, the release of aqueous Fe(II) ion was also limited (Figs  1 and 2) . In previous reports, biological iron reduction can release Fe(II) ions in the aqueous phase, but Fe(II) ions are adsorbed and/or precipitated onto the soils at the same time [5] . The formation of secondary iron minerals, such as siderite and vivianite, also results in the removal of Fe(II) ions from the aqueous phase [22] . In our other experiment, the concentration of Fe(II) ion was also limited, whereas the iron phase in adsorbed forms and/or precipitates could be detected in the soil sample [11] . By contrast, the concentration of Fe(II) ion quickly increased to over 2 mg L −1 upon treatment with 6.6 g L −1
goethite (Fig. 2b ). The increase in goethite level would provide more substrates for biological iron reduction and increase Fe(II) ion release, which might result in Fe(II) ion concentration to be higher than that of R-soil or 3.3 g L −1
goethite treatments. However, the concentration of Fe(II) ion was less than 0.5 mg L −1 during incubation with 0.3% or 2% hydrogel encapsulation. The possible reason was that hydrogel encapsulation decreased the surface area and pore volume of goethite (as shown in Table 2 ), thereby reducing the content of bioavailable Fe(II) sites. Thus, the release through biological iron reduction decreased, resulting in the limited increase in Fe(II) concentration similar to that in encapsulated R-soil or 3.3 g L −1 goethite treatment as a result of the adsorption and/or precipitation of Fe(II) ion. Roden and Zachara (1996) [23] suggested that the order of the iron reduction rates of goethite and hematite is consistent with the surface area; the reduction rate of goethite with high surface area and crystalline extent is 50 times the rate of hematite. The iron reduction rate is dependent on the surface area of hematite exposed to Geobacter sulfurreducens [13] . Thus, the structural properties played an important role during biological iron reduction.
With the addition of AQDS, the concentration of Fe(II) ion in treatment with R-soil or either concentrations of goethite increased during incubation (Figs 1 and 2) . In particular, the concentration of Fe(II) ion was higher with 100 μmol L −1 AQDS than that without AQDS upon 6.6 g L −1 goethite treatment. As previously reported, AQDS can prompt biological iron reduction as an electron shuttle compound [24] . Thus, the concentration of Fe(II) ion increased compared with treatment without AQDS. Furthermore, as simulated by the kinetic reductive dissolution model (Table 3 ), the addition of AQDS increased the value of k but decreased the value of log γ in treatments with 6.6 g L -1 goethite. Parameter k was the initial rate constant, so a high k value indicated an increase in the initial rate of reductive dissolution. Log γ represents the long-term extent of Fe(II) ion release by bioreduction, which depends on the morphology, size distribution, and reactive site density of the iron mineral undergoing dissolution. The decrease in log γ indicated an increase in the long-term extent of Fe(II) ion release [22] . This result suggested that the addition of AQDS increased the initial dissolution rate and improved the long-term extent of Fe(II) ion release, leading to the high performance [25] reported a similar description; the electron shuttle mechanism of AQDS enabled S. putrefaciens to quickly react with Fe(III) on the surface of the iron mineral and Fe(III) within the pore structure, thereby increasing the rate and extent of iron reduction.
In addition, the concentration of Fe(II) ion in R-soil treatments with 100 μmol L −1 AQDS followed the order of unencapsulated treatment > 0.3% encapsulation treatment > 2% encapsulation treatment. Once again, the structural properties infl uenced biological iron reduction. With the increase in the cross-linker ratio, the surface area and pore volume of R-soil decreased (Table 1) . Thus, the bioavailable Fe(III) sites decreased as the cross-linker ratio increased, leading to a decrease in the Fe(II) concentration. However, the effect of hydrogel encapsulation on the release of Fe(II) ion from goethite aggregates varied. During treatment with 3.3 g L −1 goethite, the concentration of Fe(II) ion followed the order of unencapsulated treatment >> 0.3% encapsulation treatment > 2% encapsulation treatment. However, with the same concentration of AQDS, the release of Fe(II) ion from 6.6 g L −1 goethite treatment followed the order of unencapsulated treatment << 0.3% encapsulation treatment < 2% encapsulation treatment. This result suggested that the infl uence of structural properties on biological iron reduction was also dependent on the content of iron-containing substrates. In addition, the value of k increased with the cross-linker ratio during treatment with 3.3 g L -1 or 6.6 g L −1 goethite, as shown in the simulation (Table 3) .
The increased k value suggested that the initial rate of Fe(II) ion release increased with hydrogel encapsulation despite the content of goethite in the system. The possible reason was that more strains of Shewanella reacted with the same goethite content compared with unencapsulated treatment under the same conditions because the surface area of goethite aggregate decreased after encapsulation. However, the effect of hydrogel encapsulation on the change in log γ was dependent on the content of Fe(III)-containing substrate. The value of log γ decreased as the cross-linker ratio increased during 6.6 g L −1 goethite treatment, which suggested that the long-term extent of Fe(II) ion release increased. By contrast, the change in log γ value with the increase in the cross-linker ratio during 3.3 g L −1 goethite treatment indicated that the long-term extent of Fe(II) ion release decreased. As previously mentioned, the change in the aqueous Fe(II) ion concentration was controlled by the interaction between Fe(II) ion release through biological iron reduction and the adsorption/precipitation of Fe(II) ion. The surface area decreased as the cross-linker ratio in 6.6 g L −1 goethite treatment increased, leading to the simultaneous decrease in both bioavailable Fe(III) sites and Fe(II) adsorption/ precipitation sites. However, the increase in the long-term extent of Fe(II) ion release suggested that the decrease in Fe(II) removal by hydrogel encapsulation played a more important role in the release of Fe(II) ion by bioreduction. In contrast, the decrease in bioavailability of goethite during 3.3 g L −1 goethite treatment had a more signifi cant role in the change in Fe(II) ion concentration. This result might be due to the different ratios of AQDS to goethite. With the same concentration of AQDS, the ratio of AQDS to goethite during 6.6 g L −1 goethite treatment was twice the ratio in 3.3 g L −1 goethite treatment. Thus, lower bioavailable Fe(III) sites exerted a greater infl uence on treatment with 3.3 g L −1 compared with 6.6 g L −1 with a suffi cient supply of AQDS. However, the ratio of AQDS to goethite increased with AQDS addition. Therefore, the interaction of both bioavailable Fe(III) sites and Fe(II) adsorption/precipitation sites was similar to that in 3.3 g L −1 treatment. In this study, the concentration of ions in unencapsulated treatment was indeed reduced to a concentration lower than that of 2% encapsulation treatment after AQDS was increased to 150 μmol L −1 or 300 μmol L −1 (Fig. 3) . However, further research should be conducted to fully understand the infl uence of structural properties on iron reduction by S. oneidensis MR-1.
Conclusions
Our data indicated that the release of Fe(II) ions from the biological iron reduction process was infl uenced by the structural property and concentration of the electron shuttle compound. The effect of structural property varied with different iron mineral contents. The simulation of the kinetic reductive dissolution model suggested that the initial rate and long-term extent of iron reduction differed among goethite aggregates, depending on the structural property and environmental condition. These differences resulted in different performances of Fe(II) ion release during the biological reduction process.
